343 related articles for article (PubMed ID: 29980907)
1. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.
Armer JM; Ballman KV; McCall L; Armer NC; Sun Y; Udmuangpia T; Hunt KK; Mittendorf EA; Byrd DR; Julian TB; Boughey JC
Support Care Cancer; 2019 Feb; 27(2):495-503. PubMed ID: 29980907
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
3. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Boughey JC; Ballman KV; Le-Petross HT; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Feliberti EC; Hunt KK
Ann Surg; 2016 Apr; 263(4):802-7. PubMed ID: 26649589
[TBL] [Abstract][Full Text] [Related]
4. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
6. Application of ACOSOG Z1071: Effect of Results on Patient Care and Surgical Decision-Making.
Palmer JAV; Flippo-Morton T; Walsh KK; Gusic LH; Sarantou T; Robinson MM; White RL
Clin Breast Cancer; 2018 Aug; 18(4):270-275. PubMed ID: 29129549
[TBL] [Abstract][Full Text] [Related]
7. Lymphedema following axillary lymph node dissection for breast cancer.
Sakorafas GH; Peros G; Cataliotti L; Vlastos G
Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
[TBL] [Abstract][Full Text] [Related]
8. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
9. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Boughey JC; Ballman KV; Hunt KK; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Le-Petross HT
J Clin Oncol; 2015 Oct; 33(30):3386-93. PubMed ID: 25646192
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Flippo-Morton TS; Kuerer HM; Bowling M; Hunt KK;
Ann Surg; 2015 Mar; 261(3):547-52. PubMed ID: 25664534
[TBL] [Abstract][Full Text] [Related]
11. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?
Specht MC; Miller CL; Russell TA; Horick N; Skolny MN; O'Toole JA; Jammallo LS; Niemierko A; Sadek BT; Shenouda MN; Finkelstein DM; Smith BL; Taghian AG
Breast Cancer Res Treat; 2013 Aug; 140(3):485-94. PubMed ID: 23912961
[TBL] [Abstract][Full Text] [Related]
12. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.
Ribeiro Pereira ACP; Koifman RJ; Bergmann A
Breast; 2017 Dec; 36():67-73. PubMed ID: 28992556
[TBL] [Abstract][Full Text] [Related]
14. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
[TBL] [Abstract][Full Text] [Related]
15. De Novo Upper Extremity Lymphedema After Elective Hand Surgery in Breast Cancer Survivors.
Baltzer HL; Harvey J; Fox PM; Moran SL
Ann Plast Surg; 2017 Jul; 79(1):24-27. PubMed ID: 28187025
[TBL] [Abstract][Full Text] [Related]
16. Improving the quality of life in breast cancer survivors at risk for lymphedema.
Bland KL; Kosir MA
Surgery; 2019 Oct; 166(4):686-690. PubMed ID: 31474490
[TBL] [Abstract][Full Text] [Related]
17. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months.
Armer JM; Stewart BR
Lymphology; 2010 Sep; 43(3):118-27. PubMed ID: 21226414
[TBL] [Abstract][Full Text] [Related]
18. Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Le-Petross HT; McCall LM; Hunt KK; Mittendorf EA; Ahrendt GM; Wilke LG; Ballman KV; Boughey JC
AJR Am J Roentgenol; 2018 Mar; 210(3):669-676. PubMed ID: 29381381
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
[TBL] [Abstract][Full Text] [Related]
20. Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.
Gennaro M; Listorti C; Mariani L; Maccauro M; Bianchi G; Capri G; Maugeri I; Lozza L; De Santis MC; Folli S
Eur J Surg Oncol; 2021 Jul; 47(7):1606-1610. PubMed ID: 33160781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
